Agile Therapeutics to Present at Noble Financial Capital Markets’ Twelfth Annual Equity Conference
16 1월 2016 - 6:32AM
Agile Therapeutics, Inc. (Nasdaq:AGRX) a women’s health specialty
pharmaceutical company focused on the development and
commercialization of new prescription contraceptive products,
announced today that Katie MacFarlane, Chief Commercial Officer,
will present at Noble Financial Capital Markets’ Twelfth Annual
Equity Conference on Monday, January 18, 2016 at 11:30 AM ET.
About Agile Therapeutics,
Inc.
Agile Therapeutics is a women's health specialty
pharmaceutical company focused on the development and
commercialization of new prescription contraceptive products. Our
product candidates are designed to provide women with contraceptive
options that offer greater convenience and facilitate compliance.
Our lead product candidate, Twirla®, (ethinyl estradiol and
levonorgestrel transdermal system), also known as AG200-15, is a
once-weekly prescription contraceptive patch currently in Phase 3
clinical development. Twirla is based on our proprietary
transdermal patch technology, called Skinfusion®, which is designed
to provide advantages over currently available patches and is
intended to optimize patch adherence and patient acceptability.
Contact Mary Coleman 609-683-1880
Agile Therapeutics (NASDAQ:AGRX)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024
Agile Therapeutics (NASDAQ:AGRX)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024